Oorsprong van het eerstegraads netwerk van Dina Radenkovic
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Gameto, Inc.
Gameto, Inc. BiotechnologyHealth Technology Gameto, Inc. is a biotechnology company based in New York, NY that focuses on developing novel treatment solutions for women's health, starting with infertility. The company's lead program, Fertilo, aims to make IVF and egg freezing shorter, safer, and more accessible through reduced hormonal injections by maturing eggs outside of the body. The company's goal is to improve assisted fertility outcomes, make the medical burden of menopause optional, and redefine female reproductive health by testing and developing drugs for ovarian disease. Gameto is led by CEO Dina Radenkovic, a physician-turned-entrepreneur, and Chairman Martin Varsavsky, a serial entrepreneur and founder of the largest fertility network, Prelude Fertility.
4
| Holding Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dina Radenkovic via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Fon Technology SL
Fon Technology SL Specialty TelecommunicationsCommunications Fon Technology SL develops shared wireless internet access network based on Wi-Fi technology. The firm's solutions enable service providers to configure, deliver and operate their own WiFi services. The company was founded by Martin Varsavsky Waisman-Diamond in 2006 and is headquartered in Madrid, Spain. | Specialty Telecommunications | Founder | |
Integrated Plasmonics Corp.
Integrated Plasmonics Corp. SemiconductorsElectronic Technology Integrated Plasmonics Corp. operates as a nanotechnology company. The company was founded on February 4, 2011 and is headquartered in San Francisco, CA. | Semiconductors | Founder | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
FT España ISP
FT España ISP Specialty TelecommunicationsCommunications Part of Orange SA, FT España ISP is a company based in Alcobendas, Spain. FT España ISP operates as an Internet service provider. The Spanish company was founded by Martín Varsavsky Waisman-Diamond. FT España ISP was acquired by Orange SA from Deutsche Telekom AG on August 01, 2007 for $432.72 million. | Specialty Telecommunications | Founder | |
Insight Venture Management LLC
Insight Venture Management LLC Investment ManagersFinance Insight Venture Management LLC (Insight Venture Partners) is a private equity and venture capital firm, a subsidiary of Insight Holdings Group LLC founded in 1995 by Jeffrey L. Horing and Jerry Fred Murdock. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
AXEL SPRINGER SE | Internet Software/Services | Director/Board Member | |
CRV LLC
CRV LLC Investment ManagersFinance Charles River Ventures, Inc. is a venture capital firm founded in 1970. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
New York University | College/University | Undergraduate Degree | |
Instituto de Empresa SL | College/University | Corporate Officer/Principal | |
Orange Espagne SA
Orange Espagne SA Specialty TelecommunicationsCommunications Orange Espagne SA is a telecommunications company. It is engaged in providing fixed telephone, mobile phone and internet services, television broadcasting, and audiovisual and interactive content. The company was founded in 1988 and is headquartered in Pozuelo de Alarcón, Spain. | Specialty Telecommunications | Founder | |
Eolia Renovables de Inversiones SCR SA
Eolia Renovables de Inversiones SCR SA Investment ManagersFinance Eolia Renovables de Inversiones SCR SA invests in mid-sized renewable energy companies located in Europe, primarily in Spain. The fund targets companies operating in the alternative power generator industry including specific wind and solar projects. | Investment Managers | Founder | |
Jazzya Investments SL
Jazzya Investments SL Miscellaneous Commercial ServicesCommercial Services Jazzya Investments SL is a private company based in Madrid, Spain. The Spanish company operates a blog that focuses on entrepreneurship. | Miscellaneous Commercial Services | Director/Board Member | |
The Varsavsky Foundation
The Varsavsky Foundation Investment Trusts/Mutual FundsMiscellaneous The Varsavsky Foundation is a grant making organization which operates an online political blog. Its projects include www.educ.ar, www.educarchile.cl, safe-democracy.org, and Atocha workshop. The company was founded by Martín Varsavsky Waisman-Diamond in May 2000 and is headquartered in Alcobendas, Spain. | Investment Trusts/Mutual Funds | Founder | |
FON Wireless Ltd.
FON Wireless Ltd. Internet Software/ServicesTechnology Services FON Wireless Ltd. Operates as a telecommunications company. The firm engages in the provision of internet access services and voice image and data transmission. The company was founded by Martín Varsavsky Waisman on November 10, 2005 and is headquartered in London, the United Kingdom. | Internet Software/Services | Founder | |
Prelude Fertility, Inc.
Prelude Fertility, Inc. Medical/Nursing ServicesHealth Services Prelude Fertility, Inc. operates as a fertility company. Its network of fertility clinics and egg donation centers offers egg freezing, egg storage, genetic testing, IVF and egg donation services. The company was founded by Martin Varsavsky Waisman in October 2016 and is headquartered in Atlanta, GA. | Medical/Nursing Services | Founder | |
Overture Life, Inc.
Overture Life, Inc. Miscellaneous Commercial ServicesCommercial Services Overture Life, Inc. operates as a biotechnology firm. The company was founded by Martin Varsavsky, Santiago Munné and José Horcajadas and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer | |
VAS Ventures
VAS Ventures Investment ManagersFinance VAS Ventures is a venture capital firm founded by Martín Varsavsky Waisman in 2017. The firm is headquartered in Spain. | Investment Managers | Founder | |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dyno Therapeutics, Inc.
Dyno Therapeutics, Inc. BiotechnologyHealth Technology Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Goggo Network GmbH
Goggo Network GmbH Packaged SoftwareTechnology Services Goggo Network GmbH develops the legal and engineering framework of European autonomous mobility networks. The company was founded by Martin Varsavsky and Yasmine Fage in September 2018 and is headquartered in Berlin, Germany. | Packaged Software | Chief Executive Officer | |
Viatel Ireland Ltd.
Viatel Ireland Ltd. Information Technology ServicesTechnology Services Viatel Ireland Ltd. provides telecommunications, cyber security, and software services. Its solutions include secure connectivity, cyber security, and colocation. The company was founded by Martín Varsavsky Waisman and is headquartered in Dublin, Ireland. | Information Technology Services | Founder | |
LEVERE HOLDINGS CORP. | Financial Conglomerates | Chief Executive Officer | |
Switch Therapeutics, Inc.
Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Pharmaceuticals: Major | Director/Board Member | |
Overture Life SL | Chief Executive Officer | ||
Barter Energia SL
Barter Energia SL Electrical ProductsProducer Manufacturing Barter Energia SL is a Spanish company that offers a new way of generating and consuming solar energy in urban areas without any investment. The company is based in Madrid, Spain and has subsidiaries in Spain. The company provides a solar community for the future. The company was founded in 2020 by Martín Varsavsky Waisman-Diamond, Maria Isabel Reija Ruiz, and Miguel Santiago Salis Canosa. Maria Isabel Reija Ruiz has been the CEO since 2020. | Electrical Products | Founder | |
Goggo Network SL | Director/Board Member | ||
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Biotechnology | Director/Board Member | |
ArrePath, Inc.
ArrePath, Inc. Information Technology ServicesTechnology Services ArrePath, Inc. is an anti-infective drug discovery company that focuses on addressing the health challenge of drug-resistant infections. The platform's proof-of-concept has been demonstrated in studies published in Cell by ArrePath's scientific founder, Zemer Gitai, Ph.D., Edwin Grant Conklin Professor of Biology at Princeton University. The company is based in Princeton, NJ, and is funded by the Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures, Viva BioInnovator, Arimed Capital, PTX Capital, and Nor'easter Ventures. The company utilizes a proprietary machine learning-based platform to efficiently identify anti-infective agents with new mechanisms of action at the outset of the discovery process. This is achieved through a deep understanding and analysis of pathogen behavior. The CEO of the company is Lloyd J. Payne. | Information Technology Services | Director/Board Member | |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
Blaudrive SL
Blaudrive SL Specialty StoresRetail Trade Part of Barter Energia SL, Blaudrive SL provides charging services for electric vehicles. The company is based in Barcelona, Spain. Blaudrive was acquired by Barter Energia SL on October 25, 2022. | Specialty Stores | Director/Board Member | |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Biotechnology | Director/Board Member | |
Vecprobio Inc.
Vecprobio Inc. Packaged SoftwareTechnology Services Vecprobio Inc. develops manufacturing technologies and tools for gene therapy. The company is based in San Diego, CA. The company was founded in 2022. Daniel Gibbs has been the CEO of the company since 2022. | Packaged Software | Chairman | |
Superluminal Medicines Inc
Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 18 |
Spanje | 14 |
Duitsland | 3 |
Verenigd Koninkrijk | 2 |
Canada | 2 |
Sectoraal
Health Technology | 8 |
Technology Services | 8 |
Communications | 6 |
Finance | 6 |
Consumer Services | 4 |
Operationeel
Founder | 17 |
Director/Board Member | 15 |
Chairman | 6 |
Chief Executive Officer | 5 |
Private Equity Investor | 3 |
Sterkste connecties
- Beurs
- Insiders
- Dina Radenkovic
- Bedrijfsconnecties